PAVmed Company Leadership

PAVM Stock  USD 7.33  0.71  10.73%   
PAVmed's insiders are aggressively buying. The analysis of insiders' sentiment of trading PAVmed Inc stock suggests that most insiders are extremely bullish at this time. PAVmed employs about 39 people. The company is managed by 11 executives with a total tenure of roughly 91 years, averaging almost 8.0 years of service per executive, having 3.55 employees per reported executive.

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2022-12-07Michael J GlennonAcquired 6666 @ 9.3View
2022-12-05Michael J GlennonAcquired 4133 @ 10.35View
Monitoring PAVmed's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.

PAVmed's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with PAVmed's future performance. Based on our forecasts, it is anticipated that PAVmed will maintain a workforce of about 40 employees by February 2026.
 
Covid

PAVmed Management Team Effectiveness

The company has return on total asset (ROA) of (0.3678) % which means that it has lost $0.3678 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1744 %, meaning that it created $0.1744 on every $100 dollars invested by stockholders. PAVmed's management efficiency ratios could be used to measure how well PAVmed manages its routine affairs as well as how well it operates its assets and liabilities. At this time, PAVmed's Return On Tangible Assets are very stable compared to the past year. As of the 4th of January 2026, Return On Assets is likely to grow to 1.23, while Return On Capital Employed is likely to drop 6.16. At this time, PAVmed's Other Current Assets are very stable compared to the past year. As of the 4th of January 2026, Non Current Assets Total is likely to grow to about 34.4 M, though Net Tangible Assets are likely to grow to (17.3 M).
As of the 4th of January 2026, Common Stock Shares Outstanding is likely to grow to about 78.8 M, though Net Loss is likely to grow to (76.3 M).
PAVmed owns a total of 27.64 Million outstanding shares. PAVmed Inc holds 19.03 pct. of its outstanding shares held by insiders and 9.31 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2015-03-31
Previous Quarter
18.1 M
Current Value
21.6 M
Avarage Shares Outstanding
11.1 M
Quarterly Volatility
16.8 M
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as PAVmed in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of PAVmed, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

PAVmed Workforce Comparison

PAVmed Inc is regarded fifth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1,208. PAVmed holds roughly 39.0 in number of employees claiming about 3% of equities under Health Care industry.
The company has Profit Margin (PM) of 106.72 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (968.8) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $968.8.

PAVmed Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific PAVmed insiders, such as employees or executives, is commonly permitted as long as it does not rely on PAVmed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, PAVmed insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2022-06-01
1.0
1
1
 400,000 
 25,935 
2022-03-01
0.9091
10
11
 1,279,350 
 1,094,825 
2021-12-01
1.0
1
1
 571,428 
 0.00 
2020-06-01
4.0
8
2
 1,050,000 
 200,921 
2020-03-01
1.0
1
1
 1,199,383 
 1,199,383 
2018-06-01
1.0909
12
11
 5,598,133 
 2,898,971 
2018-03-01
8.0
8
1
 990,216 
 34,153 
2017-12-01
0.75
6
8
 1,373,003 
 1,694,594 

PAVmed Notable Stakeholders

A PAVmed stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as PAVmed often face trade-offs trying to please all of them. PAVmed's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting PAVmed's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Dennis CPACFO PresidentProfile
Shaun MBAExecutive COOProfile
Michael GordonGeneral VPProfile
Deepika LakhaniChief VPProfile
Lishan MDChairman CEOProfile
Michael ParksVice RelationsProfile
Adrian MillerVP RelationsProfile
Matthew RileySenior RelationsProfile
Brian MDChief AffairsProfile
Victoria LeeSenior OfficerProfile
Victoria MDSenior OfficerProfile
String symbol = request.getParameter("s");

About PAVmed Management Performance

The success or failure of an entity such as PAVmed Inc often depends on how effective the management is. PAVmed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of PAVmed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the PAVmed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 1.17  1.23 
Return On Capital Employed 8.37  6.16 
Return On Assets 1.17  1.23 
Return On Equity(18.34)(17.42)

PAVmed Workforce Analysis

Traditionally, organizations such as PAVmed use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare PAVmed within its industry.

PAVmed Manpower Efficiency

Return on PAVmed Manpower

Revenue Per Employee76.8K
Revenue Per Executive272.3K
Net Income Per Employee728.9K
Net Income Per Executive2.6M
When determining whether PAVmed Inc is a strong investment it is important to analyze PAVmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PAVmed's future performance. For an informed investment choice regarding PAVmed Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(12.00)
Revenue Per Share
0.054
Quarterly Revenue Growth
(0.99)
Return On Assets
(0.37)
Return On Equity
0.1744
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.